NucliRay Defence IVS: Financial statements 2019
CVR: 37175439
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
NucliRay Defence IVS (CVR 37175439) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -1,896 and a net result of DKK -1,896 compared with DKK -3,924 the year before. Equity in the 2019 report amounted to DKK 68,133. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -1,896
- Profit/Loss
- DKK -1,896
- Equity
- DKK 68,133
- Total Assets
- DKK 68,133
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 0 | -2K | -2K | 68K | - |
| 2018 | 0 | -4K | -4K | 70K | - |
| 2017 | 0 | -61K | -61K | 65K | - |
| 2016 | 0 | -66K | -133K | 71K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
NucliRay Defence IVS has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -3,924.
About NucliRay Defence IVS
NucliRay Defence IVS was a Danish company of the type Iværksætterselskab based in København K, founded in 2015. The company has been dissolved on 6 May 2022. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2020, the company reported a net result of DKK 0 compared with DKK -1,896 the year before. Equity in the 2020 report amounted to DKK 68,133.